RXO Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of RXO Inc. - RXO
Kahn Swick & Foti, LLC says it is investigating the adequacy of the price and process in the proposed sale of RXO to C.H. Robinson. Under the stated terms, RXO shareholders would receive $17.25 in cash and 0.0856 shares of C.H. Robinson common stock per RXO share.
Why it matters — The investigation concerns the proposed transaction’s terms and process, which are relevant to RXO shareholders tracking the sale.